Matinas BioPharma Inc.
MTNB | AMEX
$1.49
-$0.02 (-1.32%)
Nov 2, 2026, 9:55 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.1M | 2.16M | 3.22M | 4.29M | 3.19M | 2.13M | 1.06M | -333 | 33K | 95.83K | 191.67K | 191.67K |
Cost of Revenue | 107K | 227K | 238K | 2.7M | 4.82M | 8.07M | 8.23M | 9.52M | 10.57M | 10.76M | 14.49M | 14.69M | 15.1M | 15.67M | 16.68M | 17.05M | 17.97M | 16.32M | 14.58M | 13.87M | 12.58M | 13.51M |
Gross Profit | -107K | -227K | -238K | -2.7M | -4.82M | -8.07M | -8.23M | -9.52M | -10.57M | -10.76M | -13.39M | -12.53M | -11.88M | -11.39M | -13.49M | -14.93M | -16.9M | -16.32M | -14.55M | -13.77M | -12.39M | -13.32M |
Operating Income | -6.67M | -6.95M | -6.96M | -13.83M | -16.63M | -20.64M | -24.59M | -22.01M | -23.76M | -24.08M | -23.77M | -23.36M | -22.69M | -22.45M | -24.59M | -25.82M | -27.24M | -26.1M | -24.74M | -24.51M | -23.24M | -24.21M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -7.31M | -11.23M | -10.96M | -17.56M | -19.69M | -20.16M | -24.33M | -21.13M | -22.91M | -23.25M | -22.94M | -21.26M | -20.67M | -20.53M | -21M | -24.06M | -25.44M | -24.3M | -23.28M | -22.92M | -21.54M | -22.36M |
Net Income | -7.31M | -11.23M | -10.96M | -17.48M | -19.61M | -20.08M | -24.25M | -21.13M | -22.91M | -23.25M | -22.94M | -21.26M | -20.67M | -20.53M | -21M | -24.06M | -25.44M | -24.3M | -23.28M | -22.92M | -21.54M | -22.36M |
Selling & General & Admin | 6.55M | 6.71M | 6.64M | 6.7M | 7.38M | 8.13M | 8.49M | 9.05M | 9.75M | 9.88M | 10.37M | 10.83M | 10.81M | 11.07M | 11.1M | 10.9M | 10.34M | 9.78M | 10.19M | 10.74M | 10.84M | 10.89M |
Research & Development | n/a | n/a | 85K | 2.46M | 4.7M | 8.07M | 11.43M | 12.72M | 13.78M | 13.97M | 14.49M | 14.69M | 15.1M | 15.67M | 16.68M | 17.05M | 17.97M | 16.32M | 14.58M | 13.87M | 12.58M | 13.51M |
Other Expenses | 11K | 11K | n/a | 1.97M | -269K | -3.64M | -3.56M | -9.28M | -10.33M | -10.52M | -14.49M | -14.69M | -15.1M | -15.67M | -16.68M | -17.05M | -17.97M | -16.32M | -14.58M | -13.87M | -12.58M | -13.51M |
Operating Expenses | 6.57M | 6.72M | 6.72M | 11.13M | 11.81M | 12.56M | 16.37M | 12.49M | 13.19M | 13.32M | 10.37M | 10.83M | 10.81M | 11.07M | 11.1M | 10.9M | 10.34M | 9.78M | 10.19M | 10.74M | 10.84M | 10.89M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -240K | -240K | -240K | -240K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 6.67M | 6.95M | 6.96M | 13.83M | 16.63M | 20.64M | 24.59M | 22.01M | 23.76M | 24.08M | 24.86M | 25.52M | 25.91M | 26.74M | 27.78M | 27.95M | 28.3M | 26.1M | 24.77M | 24.61M | 23.43M | 24.4M |
Income Tax Expense | n/a | n/a | n/a | -80K | -80K | -80K | -80K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 427.08K | 427.08K | 364.94K | 362.39K | 339.13K | 339.13K | 324.39K | 335.86K | 332.47K | 289.81K | 289.69K | 289.69K | 289.69K | 289.69K | 289.21K | 289.15K | 289.15K | 288.86K | 288.34K | 286.91K | 273.62K | 271.83K |
Shares Outstanding (Diluted) | 427.08K | 427.08K | 364.94K | 362.39K | 339.13K | 339.13K | 324.39K | 335.86K | 332.47K | 289.81K | 289.69K | 289.69K | 289.69K | 289.69K | 289.21K | 289.15K | 289.15K | 288.86K | 288.34K | 286.91K | 273.62K | 271.83K |
EPS (Basic) | -18.15 | -30.45 | -30.90 | -52.35 | -59.10 | -60.90 | -76.05 | -68.40 | -76.50 | -80.10 | -78.75 | -60.56 | -58.61 | -58.16 | -48.11 | -71.25 | -76.20 | -73.35 | -82.95 | -83.55 | -81.30 | -85.05 |
EPS (Diluted) | -18.15 | -30.45 | -30.90 | -52.35 | -59.10 | -60.90 | -76.05 | -68.40 | -76.50 | -80.10 | -78.75 | -60.56 | -58.61 | -58.16 | -48.11 | -71.25 | -76.20 | -73.35 | -82.95 | -83.55 | -80.25 | -84 |
EBITDA | -6.27M | -9.72M | -9.51M | -12.86M | -15M | -15.39M | -19.34M | -20.61M | -22.38M | -22.72M | -22.55M | -20.87M | -20.29M | -20.15M | -20.64M | -23.73M | -25.13M | -24.02M | -24.4M | -24.19M | -22.97M | -23.93M |
EBIT | -6.88M | -10.34M | -10.08M | -13.09M | -15.21M | -15.69M | -19.86M | -21.13M | -22.91M | -23.25M | -22.94M | -21.26M | -20.67M | -20.53M | -21M | -24.06M | -25.44M | -24.3M | -24.68M | -24.47M | -23.24M | -24.21M |
Depreciation & Amortization | 612K | 621K | 566K | 234K | 215K | 294K | 515K | 522K | 530K | 536K | 393K | 392K | 384K | 378K | 356K | 330.28K | 309.14K | 284.34K | 280K | 275.18K | 270.77K | 280.14K |
Add to Watchlist
Select watchlists to add or remove MTNB